Koers RavenQuest BioMed Inc. Canadian Securities Exchange
Aandelen
RQB
CA7543871080
Bedrijfsondersteunende diensten
Omzet 2017 | 0,11 0,15 0,1 | Omzet 2018 | 1,26 1,71 1,16 | Marktkapitalisatie | 58,71 mln. 79,98 mln. 54,07 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -3 mln. -4,09 mln. -2,76 mln. | Nettowinst (verlies) 2018 | -30 mln. -40,87 mln. -27,63 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 | 3,15 mln. 4,29 mln. 2,9 mln. | Nettoschuld 2018 | 12,9 mln. 17,57 mln. 11,88 mln. | EV/omzet 2018 | 56.975.119 x |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-1,55
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 89,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 35 | 27-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+12,88% | 7,83 mld. | |
-31,15% | 3,36 mld. | |
+9,80% | 2,81 mld. | |
-8,52% | 1,11 mld. | |
+21,46% | 851 mln. | |
-10,02% | 703 mln. | |
-5,18% | 595 mln. | |
-8,74% | 586 mln. | |
-9,75% | 527 mln. |